BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7854217)

  • 1. Isolation and classification of temperature-sensitive mutants of influenza B virus.
    Yamamoto-Goshima F; Aoki H; Takada T; Toda S; Yoshii S; Maeno K
    Microbiol Immunol; 1994; 38(9):757-61. PubMed ID: 7854217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.
    Shibata S; Yamamoto-Goshima F; Maeno K; Hanaichi T; Fujita Y; Nakajima K; Imai M; Komatsu T; Sugiura S
    J Virol; 1993 Jun; 67(6):3264-73. PubMed ID: 8497050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the involvement of influenza B neuraminidase in the cleavage of HA by host cell protease using low pH-induced cell fusion reaction.
    Yamamoto-Goshima F; Maeno K
    Microbiol Immunol; 1994; 38(10):819-22. PubMed ID: 7869962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and preliminary characterization of temperature-sensitive mutants of influenza virus.
    Sugiura A; Tobita K; Kilbourne ED
    J Virol; 1972 Oct; 10(4):639-47. PubMed ID: 4673486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further isolation and characterization of temperature-sensitive mutants of influenza virus.
    Sugiura A; Ueda M; Tobita K; Enomoto C
    Virology; 1975 Jun; 65(2):363-73. PubMed ID: 1168970
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of influenza recombination. III. Biochemical studies of temperature-sensitive mutants belonging to different recombination groups.
    Gregoriades A; Hirst GK
    Virology; 1976 Jan; 69(1):81-92. PubMed ID: 1246832
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutants of an influenza A reassortant which are cold-sensitive (cs) as well as temperature-sensitive (ts): on the role of the neuraminidase activity for influenza virus infection.
    Breuning A; Müller K; Scholtissek C
    Virology; 1987 Jan; 156(1):101-6. PubMed ID: 3811227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
    Fage C; Tu V; Carbonneau J; Abed Y; Boivin G
    Antivir Ther; 2017; 22(8):711-716. PubMed ID: 29082897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neuraminidase in the morphogenesis of influenza B virus.
    Yamamoto-Goshima F; Maeno K; Morishita T; Ueda M; Fujita Y; Nakajima K; Yoshii S
    J Virol; 1994 Feb; 68(2):1250-4. PubMed ID: 8289360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virion functions of RNA+ temperature-sensitive mutants of Newcastle disease virus.
    Peeples ME; Bratt MA
    J Virol; 1982 May; 42(2):440-6. PubMed ID: 7086965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens.
    Murphy BR; Spring SB; Richman DD; Tierney EL; Kasel J; Chanock RM
    Virology; 1975 Aug; 66(2):533-41. PubMed ID: 1171556
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and characterization of temperature-sensitive mutants of measles virus.
    Bergholz CM; Kiley MP; Payne FE
    J Virol; 1975 Jul; 16(1):192-202. PubMed ID: 805848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.
    Palese P; Tobita K; Ueda M; Compans RW
    Virology; 1974 Oct; 61(2):397-410. PubMed ID: 4472498
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
    Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
    J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic variation of the hemagglutinin and neuraminidase of influenza B viruses isolated in Ningbo during 2010-2012].
    Hu FJ; Li YD; Jiao SL; Zhang S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Dec; 47(12):1100-4. PubMed ID: 24529267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of temperature-sensitive mutants of Sendai virus.
    Adachi A; Kanda T; Shibuta H
    Microbiol Immunol; 1980; 24(11):1053-68. PubMed ID: 6261090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations.
    Jackson D; Barclay W; Zürcher T
    J Antimicrob Chemother; 2005 Feb; 55(2):162-9. PubMed ID: 15665027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the defective genes in three mutant groups of influenza virus.
    Ritchey MB; Palese P
    J Virol; 1977 Mar; 21(3):1196-204. PubMed ID: 850307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.
    Fujisaki S; Imai M; Takashita E; Taniwaki T; Xu H; Kishida N; Yokoyama M; Sato H; Tashiro M; Odagiri T
    J Infect Chemother; 2013 Oct; 19(5):891-5. PubMed ID: 23529501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.